A Safety and Effectiveness Study of the Tixel Device, (Fractional Peri-orbital Wrinkles Treatment ) Compared With Laser
A Prospective, Randomized, Double Arm, Controlled Study With Blinded Assessment to Evaluate the Safety and Effectiveness of the Tixel Fractional System in the Treatment of Periorbital Wrinkles in Comparison With Fractional Laser
Sponsor: Novoxel Ltd.
Terminated
Delay in recruitment as per last protocol amendment due to Covid-19
Other terminated trials from Novoxel Ltd.
More terminations from Novoxel Ltd.
A NA clinical study on Wrinkle, this trial is terminated or withdrawn. The trial is conducted by Novoxel Ltd. and has accumulated 14 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Dec 2020 — Jan 2021 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Oct 2020 — Dec 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
Jun 2020 — Oct 2020 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
-
Feb 2020 — Jun 2020 [monthly]
Withheld
-
Jul 2019 — Feb 2020 [monthly]
Withheld
-
Feb 2019 — Jul 2019 [monthly]
Withheld
-
Nov 2018 — Feb 2019 [monthly]
Withheld
-
Sep 2018 — Nov 2018 [monthly]
Withheld
-
Jun 2018 — Sep 2018 [monthly]
Withheld
-
Apr 2018 — Jun 2018 [monthly]
Withheld
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Withheld NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Novoxel Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .